ResMed, Inc. (RMD)
252.39
+0.89
(+0.35%)
USD |
NYSE |
Dec 11, 16:00
252.36
-0.03
(-0.01%)
Pre-Market: 20:00
ResMed Free Cash Flow: 1.757B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.824B |
| Abbott Laboratories | 6.917B |
| Becton, Dickinson & Co. | 2.67B |
| Insulet Corp. | 407.70M |
| West Pharmaceutical Services, Inc. | 379.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 457.32M |
| Cash from Investing (Quarterly) | -52.58M |
| Cash from Financing (Quarterly) | -230.27M |
| Free Cash Flow Per Share (Quarterly) | 2.802 |
| Free Cash Flow to Equity (Quarterly) | 417.00M |
| Free Cash Flow to Firm (Quarterly) | 411.54M |
| Free Cash Flow Yield | 4.73% |